Progressive pseudorheumatoid dysplasia is an autosomal recessive skeletal dysplasia with radiographic changes in the spine similar to Spondyloepiphyseal dysplasia tarda and clinical, though not radiographic resemblance to rheumatoid arthritis. About two-thirds of the reported patients are of Arabic and Mediterranean origin which reflects the relative high incidence in this population. We performed homozygosity mapping utilising the DNA pooling approach to map progressive pseudorheumatoid dysplasia to a chromosomal region on the long arm of chromosome 6. We examined a possible candidate gene in the same region of linkage, namely COL10A1, for alterations in this disorder. We did not identify any mutations in our family, but did not totally exclude COL10A1 gene from being the disease-causing gene.
Introduction
Progressive pseudorheumatoid dysplasia (PPD) (Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) or progressive pseudorheumatoid arthropathy of childhood (PPAC), MIM 208230) is an inherited skeletal dysplasia with radiographic changes in the spine similar to Spondyloepiphyseal dysplasia tarda with clinical, though not radiographic, resemblance to rheumatoid arthritis. 1 It is a progressive, non-inflammatory chondropathy affecting primarily the articular cartilage with characteristic skeletal abnormalities notably in the spine. 2 A review of the published reports clearly identifies its autosomal recessive inheritance and its relative high occurrence among Arabs and other Mediterranean populations. 3 The prevalence of consanguinity among Jordanians makes it possible to identify inbred families with rare recessive disorders, such that each family is independently large enough for linkage analysis. 4, 5 In one family, individuals with a rare recessive disease are likely to have inherited both copies of the mutated gene from a common ancestor, thus allowing homozygosity mapping by the DNA pooling approach. 6, 7 In this study we used this strategy to map the gene causing PPD to a locus on chromosome 6q in one inbred family from Jordan ( Figure 1 ). Linkage to chromosome 6q raised the possibility that COL10A1 might be the disease locus, but we did not identify mutations within this gene in our single family.
Materials and Methods

Pooling of DNA
DNA was extracted from dried filter card blood spots using the protocol of Descartes et al. 8 DNA concentrations were determined by spectrophotometric readings at OD 260 . After the initial concentration measurement, the samples were diluted to 20 ng/µl and a second spectrophotometric reading was obtained to confirm the new DNA concentration. All 16 samples were amplified using primers of three randomly chosen STRP markers to test the quality and concentration of DNA. Equimolar amounts of samples were pooled in three groups: 1) siblings of affecteds or parents and siblings of carriers (7.1; 7.2; 7.3; 6.2; 6.7; 6.8);
2) the five obligate carriers in the pedigree who are parents or normal offspring of affecteds (5.1; 6.1; 7.8; 8.1; 8.5);
3) the five affecteds (7.4; 7.7; 8.8; 8.9; 8.10).
Genotyping
Primers for about 350 tri and tetranucleotide tandem repeat markers covering the whole genome and spaced at about 10 cM were made available to us through CHLC. for 30 s. Products were analysed on 6% denaturing polyacrylamide gels (7.7 M urea). The polyacrylamide gels were silver-stained using the protocol of Bassam et al. 12 The amplification and digestion of amplified products for the COL10A1 restriction-site polymorphism, reported in the literature, were done according to the authors' conditions. 13 Restriction products were separated on 1% agarose gel and stained with ethidium bromide. Primers (EX 2F and EX 2.1R) ( Table 1 ) encompassing the COL10A1 polymorphic one base change (C to T; Thr 27 to Met) (poly 2) polymorphism were designed and then synthesised using phosphoramidite chemistry. The amplification was done similar to the genotyping. Amplified products were run on a fan-cooled MDE gel for SSCP analysis at 6 W for 14 h and then silver-stained.
Statistical analysis
Linkage was tested with the LOD score method using the program FASTLINK 3.0. This package requires the breaking of inbreeding loops prior to the analysis. Autosomal recessive inheritance with complete penetrance was assumed. We used a disease gene frequency of 10 -3 and equal marker allele frequencies. We varied the marker allele frequency by using frequencies obtained from the CEPH database, as well as arbitrary allele frequencies. A LOD score of 3 or greater was used as the criterion for significance. The variation in the marker allele frequency was meant to test the strength of the significant LOD scores. The reference genetic map used for the analysis was generated by CHLC from combined CEPH data. 9 Multipoint linkage analysis could not be done due to the extensive inbreeding loops.
COL10A1 sequencing
The genomic sequence of COL10A1 gene was obtained from GeneBank (accession number X98568). Six pairs of overlapping primers were designed producing 6 amplicons (Table 1 ) covering the three exons of COL10A1 gene, the splice sites and the presumed TATA box (Figure 2 ) and then synthesised using phosphoramidite chemistry. Amplification was performed with 200 ng (10 µl) of template DNA (from an affected carrier and normal individuals) in a 50 µl PCR reaction mixture, using similar conditions as outlined above under genotyping. The sizes of the products were verified on 1% agarose gel and recovered using a gel extraction kit (QIAGEN, Valencia, CA, USA). The extracted band was used for direct sequencing in both directions. The sequences generated were examined carefully for any difference in bases among the affected, carrier and normal individuals. A subset of products was also analysed by SSCP as described above. When the amplicon was longer than 200 bp it was cut with one or more restriction enzymes to produce fragments suitable for SSCP analysis.
Results
Linkage to chromosome 6
In order rapidly to screen for markers linked to the disease in this family, we constructed three pools each with a comparable number of individual samples. 6, 7, 14, 15 A genome-wide screen using the three pools was started with two pools as controls. After using 140 markers covering chromosomes 1 to 6, six markers showed reduction in the number of alleles in the affected pool. Three of the markers were located within a region of 20 cM on 6q. Accordingly, individual samples were genotyped with these markers, as well as five others from the same area. Two markers were not informative in this family, and linkage was tested by 2 point lod score method for the remaining six markers. Linkage was found with markers D6S1021 and ATA56D06 with a lod score greater than 3 at a recombination fraction of zero ( Table 2 ).
All variations in marker allele frequency gave a significant lod score, mostly even higher than the results shown in Table 2 . The telomeric boundary of the region of linkage is marked by D6S1023 (Figure 3) . One marker, D6S1270, centromeric to the region of linkage showed a crossover event in two of the five affecteds Table 2 for SSCP analysis and direct sequencing. The numbers between parenthesis denotes the length of the amplicon in base pairs.
(results not shown) and was thus considered the centromeric boundary of the region of linkage. Pairwise analysis of the two flanking markers, using CEPH family genotypes produced a critical region of about 12.9 cM on chromosome 6q16-22 between D6S1270 and D6S1023.
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Examination of COL10A1 gene
The gene encoding collagen type X (COL10A1) became a candidate gene by virtue of its location within the same chromosomal region. In addition, its role in the endochondral ossification process supports its candidacy. Two-allele, restriction-site polymorphisms reported to be within the COL10A1 gene were used to test for linkage but only one (poly 1) was informative in this family. 13 This COL10A1 intragenic variant demonstrated concordant segregation with the phenotype in this family without evidence of recombination. A reported polymorphism in the second exon of COL10A1 gene (C to T; Thr 27 to Met) (poly 2), demonstrable by SSCP analysis was used to test for linkage also indicating concordant segregation (Figure 1) (Table 2) . 16, 17 Screening by both direct sequencing and SSCP analysis, the three exons, 10-20 base pairs of intronic splice sites and the promotor region of the COL10A1 gene for mutations in an affected member of this family failed to detect any deletions or point mutations (Figure 2 ).
Discussion
The localisation of the PPD locus to chromosome 6q is supported by three observations. The first is the significant lod score with two microsatellite markers (D6S1021 and ATA56D06) mapped to 6q. The second is that affected individuals are homozygous for all tested polymorphisms in this region while obligate carriers are heterozygous for the haplotype. The third observation is concordant segregation between the disease locus and polymorphisms within COL10A1, which has been localised by two different methods (somatic cell hybrids and in situ hybridisation) to the same region on 6q. 18, 19 In instances where a recessive disorder occurs in an inbred family, an efficient DNA pooling strategy can be used as a quick screening tool for genomic loci which are identical by descent. This strategy significantly reduces the number of amplification reactions and gel lanes needed to establish linkage. In this study, we used pools from two separate populations (unaffected relatives and obligate carriers) as controls to demonstrate efficiently the reduction in the number of alleles across the pools. Three individual false positive markers were easily recognised as false as nearby flanking markers did not show a reduction in the number of alleles. The true positive results were present in a cluster. This mapping project utilised, to our knowledge, the smallest number of individuals in each pool.
Although the basic molecular defect behind PPD is unknown, we previously speculated that alterations in the cartilage specific collagen types IX or XI or both may be implicated. 3 The gene encoding type X collagen (COL10A1) became a candidate gene for this disorder by virtue of its location to the same chromosomal region. 18, 19 In addition several observations about collagen type X strengthens its candidacy. First, the restricted and transient expression of type X collagen in 20 Although there is no direct evidence, the clinical and radiographic pictures of PPD suggest an alteration in the endochondral ossification process. 3 Secondly collagen type X null mice, examined grossly till six months old and histologically not later than 3 weeks, show normal long bone growth with occasional cervical spine abnormality. 21 The clinical picture of PPD includes normal long bone length and spine abnormalities similar to the collagen type X null mouse. Although COL10A1 has been excluded as the causative gene in few other skeletal dysplasias, 22 a quantitative disturbance in the gene expression reflecting on the endochondral ossification process is consistent with the PPD phenotype and its autosomal recessive mode of inheritance.
We failed to detect any mutation in the three exons, 10-20 base pairs of intronic splice sites and the promotor region of the COL10A1 gene in this family. However, this does not totally exclude the COL10A1 gene from being the disease locus, as mutations might lie within introns or in the 3' untranslated region. In addition, mutations in regulatory regions not close to the genomic sequence of the gene might be the cause of this disorder in this family. Screening sporadic cases or patients from other unrelated families for mutations might be helpful in assigning PPD to the COL10A1 gene.
